Ziyue Zhou (Shuo Zhang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Interstitial Lung Disease

Top Venues

Nature communications

Cancer communications (London, England)

Therapeutic advances in chronic disease

This page only lists publications with an associated author ORCID identifier.

Publications

Ziyue Zhou, Chenglong Fang, Li Wang, Jing Li, Yunjiao Yang, Li Zhang, Shangyi Jin, Xiaofeng Zeng, Xinping Tian
Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre. RMD open 10 (1) (2024)
Ziyue Zhou, Chenglong Fang, Li Wang, Jing Li, Yunjiao Yang, Li Zhang, Shangyi Jin, Xiaofeng Zeng, Xinping Tian
Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre. RMD open 10 (1) (2024)
Ziyue Zhou, Xiaoxiang Zhou, Xu Jiang, Bo Yang, Xin Lu, Yunyun Fei, Lidan Zhao, Hua Chen, Li Zhang, Xiaoyan Si, Naixin Liang, Yadong Wang, Dan Yang, Yezi Peng, Yiying Yang, Zhuoran Yao, Yangzhige He, Xunyao Wu, Wen Zhang, Min Wang, Hua-Xia Yang, Xuan Zhang
Single-cell profiling identifies IL1B hi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis. Nature communications 15 (1) (2024)
Ziyue Zhou, Chenglong Fang, Li Wang, Jing Li, Yunjiao Yang, Li Zhang, Shangyi Jin, Xiaofeng Zeng, Xinping Tian
Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre. RMD open 10 (1) (2024)
Ziyue Zhou, Chenglong Fang, Li Wang, Jing Li, Yunjiao Yang, Li Zhang, Shangyi Jin, Xiaofeng Zeng, Xinping Tian
Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre. RMD open 10 (1) (2024)
Ziyue Zhou, Xiaoxiang Zhou, Xu Jiang, Bo Yang, Xin Lu, Yunyun Fei, Lidan Zhao, Hua Chen, Li Zhang, Xiaoyan Si, Naixin Liang, Yadong Wang, Dan Yang, Yezi Peng, Yiying Yang, Zhuoran Yao, Yangzhige He, Xunyao Wu, Wen Zhang, Min Wang, Hua-Xia Yang, Xuan Zhang
Single-cell profiling identifies IL1B hi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis. Nature communications 15 (1) (2024)
Ziyue Zhou, Xiaoxiang Zhou, Xu Jiang, Bo Yang, Xin Lu, Yunyun Fei, Lidan Zhao, Hua Chen, Li Zhang, Xiaoyan Si, Naixin Liang, Yadong Wang, Dan Yang, Yezi Peng, Yiying Yang, Zhuoran Yao, Yangzhige He, Xunyao Wu, Wen Zhang, Min Wang, Hua-Xia Yang, Xuan Zhang
Single-cell profiling identifies IL1B hi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis. Nature communications 15 (1) (2024)
Ziyue Zhou, Xiaoxiang Zhou, Xu Jiang, Bo Yang, Xin Lu, Yunyun Fei, Lidan Zhao, Hua Chen, Li Zhang, Xiaoyan Si, Naixin Liang, Yadong Wang, Dan Yang, Yezi Peng, Yiying Yang, Zhuoran Yao, Yangzhige He, Xunyao Wu, Wen Zhang, Min Wang, Hua-Xia Yang, Xuan Zhang
Single-cell profiling identifies IL1B hi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis. Nature communications 15 (1) (2024)
Ziyue Zhou, Huazhen Liu, Yiying Yang, Jingya Zhou, Lidan Zhao, Hua Chen, Yunyun Fei, Wen Zhang, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang, Huaxia Yang, Xuan Zhang
The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China. Cancer communications (London, England) 42 (5) (2022)
Ziyue Zhou, Ziyue Zhou, Li Wang, Mengtao Li, Fengchun Zhang, Xiaofeng Zeng
Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis. Therapeutic advances in chronic disease 12 (2021)